SCHEMBL10153684

SCHEMBL10153684

C[Si](C)(C)c1cn2c3ccc(C4(c5ccc6c(c5)c5cccc7c([Si](C)(C)C)cn6c75)CCCCC4)cc3c3cccc1c32

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
HSD11B1 P28845 3/20 0.32
HSD11B2 P80365 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153750 0.76 MAPT (0.39)
SCHEMBL10153551 0.72 HSD11B1 (0.36) ESR1ESR2HSD11B1HSD11B2
SCHEMBL10153680 0.70 EGFR (0.31)
SCHEMBL13049611 0.66 MAPT (0.54)
SCHEMBL10153711 0.65 ALKBH5 (0.41)
SCHEMBL13049587 0.64 L3MBTL1 (0.53) ESR1ESR2HSD11B1HSD11B2
SCHEMBL14649229 0.62 GPR3 (0.41) ESR1ESR2HSD11B1
SCHEMBL13049591 0.61 MAPT (0.45)
SCHEMBL10153671 0.61 SMN1; SMN2 (0.33)
SCHEMBL10153666 0.61 SMN1; SMN2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 ESR1 314/4885ESR2 696/4885HSD11B1 1561/4885
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 ESR1 314/4885ESR2 696/4885HSD11B1 1561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.